Drugs / Prasaprohyai
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03077282 | Apr → Dec 2018 | — | Thammasat University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prasaprohyai | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03077282 ↗ |
| Route | Oral | “take Prasaprohyai 95% ethanolic extract capsules at a dose of 100 mg three times a day before meals” NCT03077282 ↗ |